APA (7th ed.) Citation

JH, U., KV, B., W, W., C, G., JC, K., JC, B., . . . KA, J. (2011). Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. International journal of radiation oncology, biology, physics, 80(2), 347. https://doi.org/10.1016/j.ijrobp.2010.01.070

Chicago Style (17th ed.) Citation

JH, Uhm, et al. "Phase II Evaluation of Gefitinib in Patients with Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074." International Journal of Radiation Oncology, Biology, Physics 80, no. 2 (2011): 347. https://doi.org/10.1016/j.ijrobp.2010.01.070.

MLA (9th ed.) Citation

JH, Uhm, et al. "Phase II Evaluation of Gefitinib in Patients with Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074." International Journal of Radiation Oncology, Biology, Physics, vol. 80, no. 2, 2011, p. 347, https://doi.org/10.1016/j.ijrobp.2010.01.070.